Zeynep Çağla Üstün

Publications

• Determination of Evidence in Disputes Over Pharmaceutical Patents
  ILO - Litigation Newsletter, Co-Author, 24.01.2023
• The Danger of De Facto Abolishment of the Right to Preliminary Injunction by the Determination of Evidence in Terms of Pharmaceutical Patents
  IAM - International Report, Co-Author, 22.11.2022
• Patents, Trade Marks, Copyright and Designs 2022 in Turkey
  Practical Law, Co-Author, 09.11.2022
• Bolar-Like Hurdle for Generics
  IAM - International Report, Co-Author, 09.08.2022
• Patent Rights on Vaccines: Looking for a Scapegoat for Vaccine Inequity
  ManagingIP, Co-Author, 04.03.2022
• Are Clinical Trials Excluded From Patent Protection in Turkey?
  IAM - International Report, Co-Author, 02.03.2022
• Istanbul IP Court Reaches Landmark Decision on Precautionary Injunction
  IAM - International Report, Co-Author, 27.01.2022
• Ex-parte Preliminary Injunction Granted Against a Generic Product on Market
  ManagingIP , Co-Author, 27.05.2021
• First Precautionary Injunction Granted in Turkey to Prevent Indirectuse of a Drug Patent
  ManagingIP , Co-Author, 26.01.2021
• Discovery of Evidence and Preliminary Injunction Demands During COVID-19
  IAM - International Report, Co-Author, 09.07.2020
• “Inventing” in COVID-19 Environment and Key Local/ International Developments
  ManagingIP, Co-Author, 16.06.2020
• Is a Minor Difference From a Patented Range Enough to Win an Infringement Case?
  IAM - International Report, Co-Author, 25.03.2020
• Is the De Minimis Difference Principle Enough to Win a Case for Patent Infringement?
  Gün + Partners, Co-Author, 16.12.2019
• Patents in Europe: Helping Business Compete in the Global Economy 2019/2020
  IAM – Patents in Europe, Co-Author, 02.05.2019

Speaking Engagements